Biosenta Inc.

ZRO.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZRO.CN stands at 4.7M. In comparison, KPT.TO has a market cap of 93.1M. Regarding current trading prices, ZRO.CN is priced at CA$0.14, while KPT.TO trades at CA$9.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZRO.CN currently has a P/E ratio of -1.75, whereas KPT.TO's P/E ratio is 31.03. In terms of profitability, ZRO.CN's ROE is +0.30%, compared to KPT.TO's ROE of +0.03%. Regarding short-term risk, ZRO.CN is less volatile compared to KPT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ZRO.CN.

ZRO.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZRO.CN stands at 4.7M. In comparison, PPB.CN has a market cap of 15.4M. Regarding current trading prices, ZRO.CN is priced at CA$0.14, while PPB.CN trades at CA$0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZRO.CN currently has a P/E ratio of -1.75, whereas PPB.CN's P/E ratio is -7.00. In terms of profitability, ZRO.CN's ROE is +0.30%, compared to PPB.CN's ROE of -1.40%. Regarding short-term risk, ZRO.CN is less volatile compared to PPB.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ZRO.CN.

ZRO.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZRO.CN stands at 4.7M. In comparison, CGII.CN has a market cap of 10.1M. Regarding current trading prices, ZRO.CN is priced at CA$0.14, while CGII.CN trades at CA$0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZRO.CN currently has a P/E ratio of -1.75, whereas CGII.CN's P/E ratio is -5.33. In terms of profitability, ZRO.CN's ROE is +0.30%, compared to CGII.CN's ROE of +1.08%. Regarding short-term risk, ZRO.CN is less volatile compared to CGII.CN. This indicates potentially lower risk in terms of short-term price fluctuations for ZRO.CN.

ZRO.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZRO.CN stands at 4.7M. In comparison, MAV.TO has a market cap of 1.7M. Regarding current trading prices, ZRO.CN is priced at CA$0.14, while MAV.TO trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZRO.CN currently has a P/E ratio of -1.75, whereas MAV.TO's P/E ratio is -0.01. In terms of profitability, ZRO.CN's ROE is +0.30%, compared to MAV.TO's ROE of -2.47%. Regarding short-term risk, ZRO.CN is less volatile compared to MAV.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ZRO.CN.

ZRO.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZRO.CN stands at 4.7M. In comparison, WAY.CN has a market cap of 1.5M. Regarding current trading prices, ZRO.CN is priced at CA$0.14, while WAY.CN trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZRO.CN currently has a P/E ratio of -1.75, whereas WAY.CN's P/E ratio is N/A. In terms of profitability, ZRO.CN's ROE is +0.30%, compared to WAY.CN's ROE of +0.00%. Regarding short-term risk, ZRO.CN and WAY.CN have similar daily volatility (0.00).

ZRO.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZRO.CN stands at 4.7M. In comparison, AHC.TO has a market cap of 0. Regarding current trading prices, ZRO.CN is priced at CA$0.14, while AHC.TO trades at CA$4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZRO.CN currently has a P/E ratio of -1.75, whereas AHC.TO's P/E ratio is 7.91. In terms of profitability, ZRO.CN's ROE is +0.30%, compared to AHC.TO's ROE of +1.40%. Regarding short-term risk, ZRO.CN is less volatile compared to AHC.TO. This indicates potentially lower risk in terms of short-term price fluctuations for ZRO.CN.